About SafeStitch
SafeStitch is a publicly listed company based in Miami (United States) founded in 2005. Medical devices for gastrointestinal and bariatric surgery are developed. SafeStitch has raised $7.58 million across 8 funding rounds. The company has 167 employees. SafeStitch has completed 1 acquisition, including Asensus. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its competitors include EndoGastric Solutions, EndoChoice and CoapTech; 3 of its 3 listed competitors have raised funding.
Company details
Safe Stitch develops numerous devices in the areas of Bariatric Surgery, Reflux Interventions, Barretts Esophagus, Hernia Repair, NOTES (NO SCAR) Surgery and more. In September 2007, SafeStitch LLC completed a share exchange with Cellular Technical Services Company, a publicly-traded company, which has since been renamed SafeStitch Medical, Inc. Its medical devices manipulate tissues for endoscopic and minimally invasive surgery in the treatment of obesity, gastroesophageal reflux disease (GERD), Barretts esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation, and other intraperitoneal abnormalities. The companys product portfolio includes AMID HFD Stapler that uses non-absorbable titanium staples to repair inguinal or ventral hernias; SMART Dilator, which is used when an endoscopy demonstrates the narrowing of the esophagus; and Standard Bite Block and Airway Bite Block that are used to protect endoscope used in transoral gastrointestinal procedures. Its product candidates comprise Intralumenal Gastroplasty Device for obesity and GERD that consists of a set of instruments designed to perform endoscopic surgery by introduction through the mouth and esophagus; Barretts Excision Device for the diagnosis and treatment of Barretts esophagus; and Novel Devices for natural orifice transluminal endoscopic surgery, a method of operating in the abdominal cavity without making an incision in the abdominal wall. Since 2013, SafeStitch Medical, Inc. was acquired by TransEnterix, Inc., in a reverse merger transaction.
- Headquarters Miami, United States
- Employees 167
- Stage Public
- SectorsHealthcare
- Website safestitch.com
- Social LinkedIn
- Total Equity Funding$7.58M (USD)
in 8 rounds
- Latest Funding Round$160.37M (USD), Post-IPO
Sep 2013
- Employee Count167
- Investments & Acquisitions
Funding Insights of SafeStitch
SafeStitch has successfully raised a total of $7.58M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $160.37 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.58M
- Total Rounds 8
- Last Round Post-IPO — $160.37M
- First Round $1.58M
(Apr 2005)
All 8 funding rounds of SafeStitch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $160.37M | Post-IPO | – | – | – |
| Mar 2013 | $3.02M | Post-IPO | – | – | – |
| Feb 2012 | $8.32M | Post-IPO | – | – | – |
| Jun 2010 | $5M | Post-IPO | – | – | – |
| Jan 2010 | $2M | Post-IPO | – | – | – |
| May 2009 | $2M | Series A | – | – | – |
| Jun 2008 | $4M | Series A | – | – | – |
| Apr 2005 | $1.58M | Seed | – | – | – |
Investments & Acquisitions by SafeStitch
SafeStitch has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Asensus.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Robotic laparoscopic systems are developed for minimally invasive surgeries. | asensus.com | Durham, United States | 2006 | Aug 2013 | $170M |
Complete acquisition details for SafeStitch
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SafeStitch
5 dated milestones of SafeStitch across 8 years, from founding to its latest funding, stage changes and deals.
- Founded SafeStitch is founded.
- Funding First funding round of $1.6M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Asensus.
- Funding Latest funding round, Post-IPO, of $160.4M.
Competitors of SafeStitch
SafeStitch has 3 listed competitors in our database, 3 of them funded. They include EndoGastric Solutions, EndoChoice and CoapTech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endogastricsolutions.com | 2002 | San Mateo, United States | $355.2M | 80 | Incisionless transoral procedures for upper GI diseases are developed. | |
| endochoice.com | 2008 | Alpharetta, United States | $115.96M | 414 | Devices, systems, and services are provided for GI specialists. | |
| coaptech.com | 2016 | Baltimore, United States | $16.52M | Minimally invasive gastrostomy feeding tube placement method is developed. |
Detailed competitors of SafeStitch
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SafeStitch
Websites that share an audience with SafeStitch (safestitch.com).
Websites whose visitors overlap most with SafeStitch. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Gastroenterology
3 companies that operate in the same segment as SafeStitch (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Safestitch
Complete news archive for SafeStitch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SafeStitch
SafeStitch was founded in 2005.
SafeStitch is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
SafeStitch is a funded company, having raised a total of $7.58M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1.58M, raised on Apr 2005.
SafeStitch has 167 employees.
Safe Stitch develops numerous devices in the areas of Bariatric Surgery, Reflux Interventions, Barretts Esophagus, Hernia Repair, NOTES (NO SCAR) Surgery and more. In September 2007, SafeStitch LLC completed a share exchange with Cellular Technical Services Company, a publicly-traded company, which has since been renamed SafeStitch Medical, Inc. Its medical devices manipulate tissues for endoscopic and minimally invasive surgery in the treatment of obesity, gastroesophageal reflux disease (GERD), Barretts esophagus, esophageal obstructions, upper gastrointestinal bleeding, hernia formation, and other intraperitoneal abnormalities. The companys product portfolio includes AMID HFD Stapler that uses non-absorbable titanium staples to repair inguinal or ventral hernias; SMART Dilator, which is used when an endoscopy demonstrates the narrowing of the esophagus; and Standard Bite Block and Airway Bite Block that are used to protect endoscope used in transoral gastrointestinal procedures. Its product candidates comprise Intralumenal Gastroplasty Device for obesity and GERD that consists of a set of instruments designed to perform endoscopic surgery by introduction through the mouth and esophagus; Barretts Excision Device for the diagnosis and treatment of Barretts esophagus; and Novel Devices for natural orifice transluminal endoscopic surgery, a method of operating in the abdominal cavity without making an incision in the abdominal wall. Since 2013, SafeStitch Medical, Inc. was acquired by TransEnterix, Inc., in a reverse merger transaction.
SafeStitch's top competitors include CoapTech, EndoChoice and EndoGastric Solutions.
SafeStitch has made 1 acquisition, including Asensus.